Related Experiment Video
Updated: Sep 20, 2025

High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
Identifying New COVID-19 Variants from Spike Proteins Using Novelty Detection
Sayantani Basu1, Roy H Campbell1
1Department of Computer Science, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States.
Machine learning novelty detection accurately identified COVID-19 variants B.1.1.7 and B.1.351 using spike protein sequences. Automated variant detection aids in developing timely mitigation measures and effective vaccines.
Area of Science:
- Virology
- Computational Biology
- Machine Learning
Background:
- The COVID-19 pandemic continues with the emergence of new viral variants.
- Machine learning has proven valuable in analyzing the virus and its impact.
- Early detection of variants is crucial for public health responses.
Purpose of the Study:
- To apply novelty detection algorithms for identifying specific COVID-19 variants.
- To evaluate the accuracy of these algorithms on viral spike protein sequences.
Main Methods:
- Utilized novelty detection algorithms, specifically One Class SVM.
- Applied fine-tuned parameters to analyze ProtVec unaligned COVID-19 spike protein sequences.
- Tested algorithms on B.1.1.7 and B.1.351 variants.
Main Results:
- Achieved 79.64% accuracy for the B.1.1.7 variant.
- Achieved 82.43% accuracy for the B.1.351 variant.
- Demonstrated the effectiveness of machine learning in variant detection.
Conclusions:
- Automated and timely detection of COVID-19 variants is feasible using machine learning.
- This technology can support the development of targeted medicines and vaccines.
- Facilitates informed public health strategies and pandemic mitigation efforts.
More Related Videos
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024